Almost daily, President Donald Trump and leaders worldwide say they are racing to develop a coronavirus vaccine, in perhaps the most urgent mission in the history of medical science. But the repeated assurances of near-miraculous speed are exacerbating a problem that has largely been overlooked and one
A growing number of polls find so many people saying they would not get a coronavirus vaccine that its potential to shut down the pandemic could be in jeopardy. Distrust of it is particularly pronounced in African American communities, which have been disproportionately devastated by the virus. But even many staunch supporters of immunization say they are wary of this vaccine.
The fastidious process to develop a safe, effective vaccine typically takes a decade; some have taken far longer. But the administration of Trump, himself once an outspoken vaccine skeptic, has been saying recently that a coronavirus vaccine could be ready this fall. While it has removed certain conventional barriers, such as funding, many experts still believe that the proposed timeline could be unduly optimistic.
The researchers noted that although billions of federal dollars were pouring into biomedical research for a vaccine, there seemed to be virtually no funding set aside for social scientists to investigate hesitancy around vaccines. Focus groups to help pinpoint the most effective messaging to counter opposition, the authors said, should get underway immediately.
“The trust issues are just tremendous in the Black community,” said Edith Perry, a member of the Maryland Community Research Advisory Board, which seeks to ensure that the benefits of health research encompass Black and Latino communities. His clients and their families are still leery of drug companies, he said. “It’s hard to trust that they’re looking out for our well-being,” he continued. “Me, I’m very skeptical about that shot. I have my popcorn and my soda and I’m just watching it very carefully.”
Emily Brunson, a medical anthropologist at Texas State University, said that the myriad number of reasons people may be skeptical of this vaccine, combined with the vast, unsparing reach of COVID-19 itself, meant that creating a campaign for the vaccine’s acceptance would be far more difficult than one for a more narrowly defined group — shingles vaccine for older people, HPV vaccine for preteens.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Economic outlook: Consumer sentiment reverses rebound amid virus spike - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Russia's Fancy Bear and Cozy Bear hacking groups are under the spotlightTwo hacking groups linked to Russia are under the spotlight and one of them has been accused of trying to steal coronavirus vaccine secrets.
Read more »
Goldman Sachs says a coronavirus vaccine could be approved later in 2020An analyst at Goldman Sachs thinks a coronavirus vaccine could be approved before year-end by the U.S. as the country tries to stem a massive uptick in cases.
Read more »
Russia tried to hack coronavirus vaccine research, US, UK and Canada say'A cyber espionage group, almost certainly part of the Russian intelligence services' attempted to hack coronavirus vaccine research, U.K., U.S. and Canada allege.
Read more »
Live Nation Shares Bounce on Encouraging Vaccine TrialAs markets reacted enthusiastically to a promising coronavirus vaccine trial, shares of concert promoter Live Nation leaped 12.2% to $52.09 on Wednesday before closing at $51.84, up 11.7%.
Read more »
Chinese executives get 'pre-test' injections in vaccine raceA state-owned Chinese company’s claim that top executives and employees rolled up their sleeves for its COVID-19 vaccine before it got permission for human testing is raising ethical concerns among health experts.
Read more »